Bitcoin will hit $130,000 this year, wealth advisor says
Subtitles
  • Off
  • English

Tesla stock is the worst, Ozempic scares food CEOs, Chanel's fake purse: This week's most popular stories

Tesla stock is the worst, Ozempic scares food CEOs, Chanel's fake purse: This week's most popular stories

Plus, US-China competition is "about to get very real," and layoffs hit the healthcare sector

We may earn a commission from links on this page.
Start Slideshow

Tesla’s rough start to 2024 continued as it hit the way bottom of the S&P 500. Novo Nordisk’s CEO said food company executives are so scared of weight loss drugs that they’re calling him for advice. Chanel finally has a new definition of a “fake purse.” And more.

Advertisement

These are some of the most popular Quartz stories from this week.


Advertisement
Previous Slide
Next Slide
A Tesla is being lifted out of a fjord.
In need of a rescue.
Photo: Håkon Mosvold Larsen / NTB / AFP via Getty Images (Getty Images)

Poor Tesla. All those recalls, a CEO whose drug use is allegedly so bad his rich friends on the board reportedly want him to head to rehab, increased competition at home and abroad. And as Valentine’s Day approaches, it keeps getting broken up with again and again and again: Investors are ditching its stock en masse, sending it down 24% for the year — a year that’s barely in its second month. 

Advertisement

Read More

Advertisement
Previous Slide
Next Slide
Tesla car chargers in Korea
Only 10% of EV chargers in Korea are fast chargers, according to the International Energy Agency
Image: Kim Hong-Ji (Reuters)

Tesla sold only one car this January in South Korea, according to new data, as consumers there remain concerned with inflation and Elon Musk’s EV company continues to deal with a lack of chargers in the country. 

Advertisement

Read More

Advertisement
Previous Slide
Next Slide
Wegovy injections
Novo Nordisk reported on Jan. 31 that its revenue in 2023 jumped 31% to 232.3 billion Danish kroner ($33.8 billion).
Image: Staff (Reuters)

Lars Fruergaard Jorgensen, the CEO of Ozempic and Wegovy maker Novo Nordisk, says that chief executives at food companies are calling him for advice regarding the diabetes and weight loss drugs

Advertisement

Read More

Advertisement
Previous Slide
Next Slide
A quilted red Chanel coin pouch belt bag.
Karlie Kloss wore this bag to a What Goes Around Comes Around anniversary party in 2017.
Photo: Steve Granitz/WireImage (Getty Images)

Back in 2018, Chanel sued a luxury fashion reseller called What Goes Around Comes Around (WGACA). The French handbag-and-makeup giant, which will go to distant ends to protect its intellectual property and reputation, didn’t like the means that WGACA was using to drum up interest in its pre-owned wares—Chanel-associated hashtags, old display stands, stuff like that—and made a call to its lawyers. Nearly six years later, enough paperwork had been passed back and forth at the courthouse for the case to go in front of a jury. On Tuesday (Feb. 6), that jury ruled in Chanel’s favor. 

Advertisement

Read More

Advertisement
Previous Slide
Next Slide
Image for article titled Tesla stock is the worst, Ozempic scares food CEOs, Chanel's fake purse: This week's most popular stories
Photo: Andrew Kelly (Reuters)

Palantir has long positioned itself as a leader in technologies that will define the modern battlefield. The contours of that battlefield are now coming more clearly into view, says Alexander Karp, CEO of the data analytics company. 

Advertisement

Read More

Advertisement
Previous Slide
Next Slide
A registered nurse cares for a patient on a stretcher in a hallway of a California hospital
A registered nurse cares for a patient on a stretcher in a hallway of a California hospital
Image: Mario Tama (Getty Images)

Tech and media layoffs have made big splashes across news headlines. But another industry’s workforce has faced troubles, too: healthcare. 

Advertisement

Read More

Advertisement